Type 2 diabetes mellitus is a major metabolic disorder characterized by persistent elevation of blood glucose.

Insulin resistance is one of its most important underlying abnormalities.

Under normal conditions, insulin binds to its receptor on target cells and activates intracellular signaling pathways that promote glucose uptake and regulate lipid and protein metabolism.

In insulin-resistant states, this signaling process becomes impaired.

Skeletal muscle, adipose tissue, and liver are particularly important tissues in the development of systemic insulin resistance.

The molecular mechanisms involved are complex and are influenced by obesity, excess nutrient availability, inflammation, oxidative stress, and genetic factors.

Insulin Signaling and Its Disruption

Insulin binds to the insulin receptor, resulting in receptor activation and phosphorylation of insulin receptor substrate proteins.

This activates phosphoinositide 3-kinase and AKT signaling.

In skeletal muscle and adipose tissue, the pathway promotes movement of glucose transporter 4 to the cell membrane, increasing glucose uptake.

In insulin resistance, phosphorylation and activity of important signaling proteins become abnormal.

As a result, glucose uptake decreases and metabolic regulation becomes impaired.

Role of Inflammation

Chronic low-grade inflammation is strongly associated with insulin resistance.

Adipose tissue expansion can increase production of inflammatory mediators such as tumor necrosis factor-alpha and interleukin-6.

These mediators can interfere with insulin receptor substrate signaling.

Activation of inflammatory pathways, including nuclear factor-kappa B and stress-activated protein kinases, can further impair insulin action.

Consequently, inflammation creates a metabolic environment that promotes persistent insulin resistance.

Oxidative Stress and Mitochondrial Dysfunction

Excessive production of reactive oxygen species can damage cellular components and interfere with insulin signaling.

Oxidative stress may affect proteins involved in glucose metabolism and activate stress-response pathways that reduce insulin sensitivity.

Mitochondrial dysfunction can also contribute by reducing efficient energy metabolism and increasing oxidative stress.

These mechanisms may be particularly important in metabolically active tissues such as skeletal muscle and liver.

Lipid Accumulation

Excess circulating fatty acids and lipid accumulation within non-adipose tissues can contribute to insulin resistance.

Accumulation of lipid intermediates such as diacylglycerols and ceramides can activate signaling pathways that interfere with insulin action.

In the liver, increased lipid accumulation can impair insulin-mediated suppression of glucose production.

This contributes to fasting hyperglycemia, a major feature of type 2 diabetes.

Adipose Tissue and Adipokines

Adipose tissue functions as an endocrine organ and releases numerous signaling molecules known as adipokines.

Adiponectin generally promotes insulin sensitivity, whereas several inflammatory adipokines can contribute to metabolic dysfunction.

In obesity and insulin resistance, adipokine secretion becomes dysregulated.

Reduced adiponectin levels and increased inflammatory signaling may therefore contribute to impaired insulin action.

This article was prepared as a concise narrative review of the molecular mechanisms involved in insulin resistance.

Relevant scientific literature concerning insulin signaling, inflammation, oxidative stress, mitochondrial dysfunction, lipid metabolism, and adipokine regulation was considered.

The available evidence was synthesized to summarize the principal molecular pathways contributing to insulin resistance in type 2 diabetes.

Results

The reviewed evidence indicates that insulin resistance is a multifactorial process involving several interconnected molecular pathways.

Impaired insulin receptor substrate and PI3K-AKT signaling reduces glucose uptake.

Inflammatory signaling can further inhibit insulin action, while oxidative stress and mitochondrial dysfunction contribute to cellular metabolic abnormalities.

Lipid accumulation and altered adipokine secretion provide additional mechanisms through which obesity and metabolic dysfunction promote insulin resistance.

Insulin resistance develops through interactions between genetic susceptibility, excessive nutrient availability, adipose tissue dysfunction, inflammation, and cellular stress.

The PI3K-AKT pathway is particularly important because disruption of this pathway directly affects glucose transport and metabolism.

However, insulin resistance cannot be explained by a single molecular defect.

Inflammation, oxidative stress, lipid accumulation, and mitochondrial dysfunction interact with insulin signaling and may reinforce one another.

Understanding these interactions may help identify more effective therapeutic approaches.

Lifestyle interventions that improve body composition and metabolic health can improve insulin sensitivity.

Pharmacological therapies may also target different aspects of glucose regulation and insulin action.

Future research focused on molecular subtypes of insulin resistance may support more individualized treatment strategies.

Insulin resistance is a complex molecular disorder that plays a central role in type 2 diabetes.

Defective insulin signaling, inflammation, oxidative stress, mitochondrial dysfunction, lipid accumulation, and adipokine imbalance all contribute to reduced insulin sensitivity.

A better understanding of these pathways may facilitate the development of targeted therapies and improve prevention strategies.

1. Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiological Reviews. 2018;98:2133–2223.
2. Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nature Medicine. 2017;23:804–814.
3. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Journal of Clinical Investigation. 2016;126:12–22.
4. Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxidative Medicine and Cellular Longevity. 2020;2020:8609216.
5. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177–185.
6. Petersen KF, Shulman GI. Etiology of insulin resistance. American Journal of Medicine. 2006;119:S10–S16.
7. Sun Q, van Dam RM, Willett WC, Hu FB. Prospective study of adiponectin and risk of type 2 diabetes. Diabetes Care. 2009;32:2025–2030.